HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 5, 3862-3874, February 4, 2005

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 280/5/3862    most recent M407435200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by An, F.-Q. Articles by Renne, R. Search for Related Content PubMed PubMed Citation Articles by An, F.-Q. Articles by Renne, R. Social Bookmarking                      What's this?

The Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Modulates Cellular Gene Expression and Protects Lymphoid Cells from p16 INK4A-induced Cell Cycle Arrest^*

Feng-Qi An, Nicole Compitello, Edward Horwitz, Michael Sramkoski, Erik S. Knudsen¶, and Rolf Renne||

From the Division of Hematology/Oncology and the Department of Molecular Biology and Microbiology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106 and the ^¶Department of Cell Biology, University of Cincinnati, Cincinnati, Ohio 45229

Latently infected Kaposi's sarcoma-associated herpes-virus (KSHV)-associated tumor cells have both endothelial and lymphoid origins and express a limited set of latent viral genes. One such gene, ORF73, encodes the latency-associated nuclear antigen (LANA), a multifunctional protein that plays roles in viral DNA replication, episome maintenance, and transcriptional regulation. LANA interacts with cellular proteins involved in transcriptional regulation such as the tumor suppressors, retinoblastoma (Rb) and p53, and RING3 family members. Although several reports about specific LANA-regulated promoters exist, only limited data are available that address how LANA expression in KSHV-infected cells globally affects cellular gene expression, thereby potentially contributing to KSHV pathogenicity. To investigate this question, we generated an Epstein-Barr virus-negative Burkitts lymphoma line that expresses LANA from a tetracycline-inducible promoter (BJAB/Tet-On/LANA), and we performed microarray-based gene expression profiling. Expression profiling at different time points post-induction revealed that 186 genes were activated or repressed over 2-fold in the presence of LANA. Of these genes, 41 are regulated in the Rb/E2F pathway, whereas 7 are related to p53 signaling. To determine whether these gene expression changes translate into LANA-dependent changes in cell cycle regulation, we overexpressed p16 INK4a, a CDK4/6 inhibitor that efficiently induces cell cycle arrest in Rb-positive cells. Under these conditions, LANA expression protects lymphoid cells from p16 INK4a-induced cell cycle arrest and induces S-phase entry.

Received for publication, July 2, 2004 , and in revised form, October 29, 2004.

^* This work was supported by grants from the American Cancer Society and National Institutes of Health Grants CA88763 and CA097939 (to R. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables 1-3.

^|| To whom correspondence should be addressed: Dept. of Molecular Genetics and Microbiology and Shands Cancer Center, University of Florida, Gainesville, FL 32610. Tel.: 352-392-9848; Fax: 352-392-5802; E-mail: rrenne{at}ufscc.ufl.edu.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Lu, S. C. Verma, M. Murakami, Q. Cai, P. Kumar, B. Xiao, and E. S. Robertson Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Upregulates Survivin Expression in KSHV-Associated B-Lymphoma Cells and Contributes to Their Proliferation J. Virol., July 15, 2009; 83(14): 7129 - 7141. [Abstract] [Full Text] [PDF]

				N. Faumont, C. Le Clorennec, P. Teira, G. Goormachtigh, J. Coll, Y. Canitrot, C. Cazaux, J.-S. Hoffmann, P. Brousset, G. Delsol, et al. Regulation of DNA Polymerase {beta} by the LMP1 Oncoprotein of EBV through the Nuclear Factor-{kappa}B Pathway Cancer Res., June 15, 2009; 69(12): 5177 - 5185. [Abstract] [Full Text] [PDF]

				B. Kelley-Clarke, E. De Leon-Vazquez, K. Slain, A. J. Barbera, and K. M. Kaye Role of Kaposi's Sarcoma-Associated Herpesvirus C-Terminal LANA Chromosome Binding in Episome Persistence J. Virol., May 1, 2009; 83(9): 4326 - 4337. [Abstract] [Full Text] [PDF]

				M. Ottinger, D. Pliquet, T. Christalla, R. Frank, J. P. Stewart, and T. F. Schulz The Interaction of the Gammaherpesvirus 68 orf73 Protein with Cellular BET Proteins Affects the Activation of Cell Cycle Promoters J. Virol., May 1, 2009; 83(9): 4423 - 4434. [Abstract] [Full Text] [PDF]

				D. L. Di Bartolo, M. Cannon, Y.-F. Liu, R. Renne, A. Chadburn, C. Boshoff, and E. Cesarman KSHV LANA inhibits TGF-{beta} signaling through epigenetic silencing of the TGF-{beta} type II receptor Blood, May 1, 2008; 111(9): 4731 - 4740. [Abstract] [Full Text] [PDF]

				J. C. Forrest, C. R. Paden, R. D. Allen III, J. Collins, and S. H. Speck ORF73-Null Murine Gammaherpesvirus 68 Reveals Roles for mLANA and p53 in Virus Replication J. Virol., November 1, 2007; 81(21): 11957 - 11971. [Abstract] [Full Text] [PDF]

				J. Liu, H. J. Martin, G. Liao, and S. D. Hayward The Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Stabilizes and Activates c-Myc J. Virol., October 1, 2007; 81(19): 10451 - 10459. [Abstract] [Full Text] [PDF]

				R. L. Skalsky, J. Hu, and R. Renne Analysis of Viral cis Elements Conferring Kaposi's Sarcoma-Associated Herpesvirus Episome Partitioning and Maintenance J. Virol., September 15, 2007; 81(18): 9825 - 9837. [Abstract] [Full Text] [PDF]

				J. Liu, H. Martin, M. Shamay, C. Woodard, Q.-Q. Tang, and S. D. Hayward Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Downregulates Nuclear Glycogen Synthase Kinase 3 Activity and Consequently Blocks Differentiation J. Virol., May 1, 2007; 81(9): 4722 - 4731. [Abstract] [Full Text] [PDF]

				B. Kelley-Clarke, M. E. Ballestas, V. Srinivasan, A. J. Barbera, T. Komatsu, T.-A. Harris, M. Kazanjian, and K. M. Kaye Determination of Kaposi's Sarcoma-Associated Herpesvirus C-Terminal Latency-Associated Nuclear Antigen Residues Mediating Chromosome Association and DNA Binding J. Virol., April 15, 2007; 81(8): 4348 - 4356. [Abstract] [Full Text] [PDF]

				M. Ottinger, T. Christalla, K. Nathan, M. M. Brinkmann, A. Viejo-Borbolla, and T. F. Schulz Kaposi's Sarcoma-Associated Herpesvirus LANA-1 Interacts with the Short Variant of BRD4 and Releases Cells from a BRD4- and BRD2/RING3-Induced G1 Cell Cycle Arrest J. Virol., November 1, 2006; 80(21): 10772 - 10786. [Abstract] [Full Text] [PDF]

				M. Shamay, A. Krithivas, J. Zhang, and S. D. Hayward Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA PNAS, September 26, 2006; 103(39): 14554 - 14559. [Abstract] [Full Text] [PDF]

				S. A. R. Rezaee, C. Cunningham, A. J. Davison, and D. J. Blackbourn Kaposi's sarcoma-associated herpesvirus immune modulation: an overview J. Gen. Virol., July 1, 2006; 87(7): 1781 - 1804. [Abstract] [Full Text] [PDF]

				S. D. Hayward, J. Liu, and M. Fujimuro Notch and Wnt Signaling: Mimicry and Manipulation by Gamma Herpesviruses Sci. Signal., May 16, 2006; 2006(335): re4 - re4. [Abstract] [Full Text] [PDF]

				P. W. Ford, B. A. Bryan, O. F. Dyson, D. A. Weidner, V. Chintalgattu, and S. M. Akula Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1139 - 1144. [Abstract] [Full Text] [PDF]

				F.-Q. An, H. M. Folarin, N. Compitello, J. Roth, S. L. Gerson, K. R. McCrae, F. D. Fakhari, D. P. Dittmer, and R. Renne Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In Vivo. J. Virol., May 1, 2006; 80(10): 4833 - 4846. [Abstract] [Full Text] [PDF]

				H. Si and E. S. Robertson Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Induces Chromosomal Instability through Inhibition of p53 Function J. Virol., January 15, 2006; 80(2): 697 - 709. [Abstract] [Full Text] [PDF]

				A. Viejo-Borbolla, M. Ottinger, E. Bruning, A. Burger, R. Konig, E. Kati, J. A. Sheldon, and T. F. Schulz Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1 J. Virol., November 1, 2005; 79(21): 13618 - 13629. [Abstract] [Full Text] [PDF]

				M. Fujimuro, J. Liu, J. Zhu, H. Yokosawa, and S. D. Hayward Regulation of the Interaction between Glycogen Synthase Kinase 3 and the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen J. Virol., August 15, 2005; 79(16): 10429 - 10441. [Abstract] [Full Text] [PDF]

				M. A. Samols, J. Hu, R. L. Skalsky, and R. Renne Cloning and Identification of a MicroRNA Cluster within the Latency-Associated Region of Kaposi's Sarcoma-Associated Herpesvirus J. Virol., July 15, 2005; 79(14): 9301 - 9305. [Abstract] [Full Text] [PDF]